HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Acute anterior non-granulomatous uveitis after intravitreal injection of bevacizumab].

AbstractBACKGROUND:
Recently, bevacizumab (Avastin(R)) has been used widely as a potential off-label treatment of CNV. The ocular side effects appear to be quite rare, but one concern is the risk of an inflammatory response. We report on an acute nong-ranulomatous anterior uveitis after intravitreal injection of bevacizumab.
HISTORY AND SIGNS:
A 74-year-old female with subfoveal CNV due to ARMD presented after the second injection of bevacizumab with a symptomatic acute non-granulomatous anterior uveitis. Work-up ruled out any other aetiology.
THERAPY AND OUTCOME:
Treatment with topical prednisolone and scopolamine resolved inflammation and symptoms.
CONCLUSIONS:
Intravitreal injection of bevacizumab is related with the possible development of acute non-granulomatous anterior uveitis, after having excluded infectious or other causes of uveitis unrelated to the bevacizumab injection. In recent clinical trials bevacizumab-induced uveitis has been demonstrated to be a rare event. The pathogenesis remains unclear. One possible explanation is the Fc portion of the antibody, which may offer the possibility of an increased cellular immune response. This case underlines the importance to inform patients about the possibility of such an episode.
AuthorsS Hasler, M K Schmid, C N Becht
JournalKlinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 225 Issue 5 Pg. 446-7 (May 2008) ISSN: 0023-2165 [Print] Germany
Vernacular TitleAkute anteriore nichtgranulomatöse Uveitis nach intravitrealer Bevacizumab-Injektion.
PMID18454394 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
Topics
  • Aged
  • Antibodies, Monoclonal (administration & dosage, adverse effects)
  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Female
  • Granuloma (chemically induced, diagnosis)
  • Humans
  • Injections (adverse effects)
  • Uveitis, Anterior (chemically induced, diagnosis)
  • Vitreous Body (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: